标题
Different endotypes and phenotypes drive the heterogeneity in severe asthma
作者
关键词
-
出版物
ALLERGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-07-03
DOI
10.1111/all.13966
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
- (2018) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma
- (2018) Paul M. O’Byrne et al. NEW ENGLAND JOURNAL OF MEDICINE
- As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma
- (2018) Eric D. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis
- (2018) Helen L Petsky et al. THORAX
- A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial
- (2018) Catherine E. Hanratty et al. Trials
- Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
- (2018) Reynold A Panettieri et al. Lancet Respiratory Medicine
- Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
- (2018) Thomas B. Casale et al. Journal of Allergy and Clinical Immunology-In Practice
- Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Non-Adherence in Severe Asthma
- (2018) Liam G Heaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sorting Out Nonadherence and Airway Inflammation in Treatment Escalation for Severe Asthma
- (2018) Bruce G Bender AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma
- (2017) Shawn D. Aaron et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized multicenter study evaluating Xolair persistence of response after long-term therapy
- (2017) Dennis Ledford et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
- (2017) Peter G Gibson et al. LANCET
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
- (2017) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tezepelumab in Adults with Uncontrolled Asthma
- (2017) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cough and severe asthma
- (2017) Liam G. Heaney PULMONARY PHARMACOLOGY & THERAPEUTICS
- Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study
- (2016) I. Mogensen et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Treatable traits: toward precision medicine of chronic airway diseases
- (2016) Alvar Agusti et al. EUROPEAN RESPIRATORY JOURNAL
- Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma
- (2016) Pinja Ilmarinen et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
- (2016) Eugene R Bleecker et al. LANCET
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) J Mark FitzGerald et al. LANCET
- Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
- (2016) Joan Sweeney et al. THORAX
- Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease
- (2016) Jay Thakkar et al. JAMA Internal Medicine
- Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
- (2016) Paul M O'Byrne et al. Lancet Respiratory Medicine
- Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
- (2016) Nicola A Hanania et al. Lancet Respiratory Medicine
- The prevalence of severe refractory asthma
- (2015) Pieter-Paul W. Hekking et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
- (2015) David F. Choy et al. Science Translational Medicine
- Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)
- (2015) Liam G Heaney et al. THORAX
- Blood or sputum eosinophils to guide asthma therapy?
- (2015) Manali Mukherjee et al. Lancet Respiratory Medicine
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
- (2014) Pranabashis Haldar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Inhaler reminders improve adherence with controller treatment in primary care patients with asthma
- (2014) Juliet M. Foster et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Patient reminder systems and asthma medication adherence: a systematic review
- (2014) Nancy Tran et al. JOURNAL OF ASTHMA
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Exploring the Effects of Omalizumab in Allergic Asthma
- (2013) Nicola A. Hanania et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects
- (2013) Andrei Malinovschi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Obesity and asthma: A coincidence or a causal relationship? A systematic review
- (2013) Zarqa Ali et al. RESPIRATORY MEDICINE
- The Utility of Fractional Exhaled Nitric Oxide Suppression in the Identification of Nonadherence in Difficult Asthma
- (2012) Diarmuid M. McNicholl et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Large Subgroup of Mild-to-Moderate Asthma Is Persistently Noneosinophilic
- (2012) Kelly Wong McGrath et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
- (2012) Mercedes Rincon et al. International Journal of Biological Sciences
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- The relationship between clinical outcomes and medication adherence in difficult-to-control asthma: Table 1
- (2012) Anna C Murphy et al. THORAX
- An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications
- (2011) Raed A. Dweik et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Utility of Cardiopulmonary Exercise Testing in Difficult Asthma
- (2011) Diarmuid M. McNicholl et al. CHEST
- Non-adherence in difficult asthma: time to take it seriously
- (2011) Liam G Heaney et al. THORAX
- Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)
- (2010) E. H. Bel et al. THORAX
- The Prevalence of Nonadherence in Difficult Asthma
- (2009) Jacqueline Gamble et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
- (2009) Prescott G. Woodruff et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma
- (2009) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The importance of nurse-led home visits in the assessment of children with problematic asthma
- (2009) M Bracken et al. ARCHIVES OF DISEASE IN CHILDHOOD
- The major inflammatory mediator interleukin-6 and obesity
- (2009) Katalin Eder et al. INFLAMMATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now